{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["keratinocyte carcinoma", "medicinal plants", "phytochemistry", "transdermal drug delivery systems"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33915735", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "24"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "01"}], "Language": ["eng"], "ELocationID": ["1979", "10.3390/molecules26071979"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "7", "PubDate": {"Year": "2021", "Month": "Apr", "Day": "01"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Pathogenesis of Keratinocyte Carcinomas and the Therapeutic Potential of Medicinal Plants and Phytochemicals.", "Abstract": {"AbstractText": ["Keratinocyte carcinoma (KC) is a form of skin cancer that develops in keratinocytes, which are the predominant cells present in the epidermis layer of the skin. Keratinocyte carcinoma comprises two sub-types, namely basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). This review provides a holistic literature assessment of the origin, diagnosis methods, contributing factors, and current topical treatments of KC. Additionally, it explores the increase in KC cases that occurred globally over the past ten years. One of the principal concepts highlighted in this article is the adverse effects linked to conventional treatment methods of KC and how novel treatment strategies that combine phytochemistry and transdermal drug delivery systems offer an alternative approach for treatment. However, more in vitro and in vivo studies are required to fully assess the efficacy, mechanism of action, and safety profile of these phytochemical based transdermal chemotherapeutics."]}, "AuthorList": [{"Identifier": ["0000-0001-6476-7815"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "DST-CSIR National Centre for Nanostructured Materials, Council for Scientific and Industrial Research, Pretoria 0001, South Africa."}, {"Identifier": [], "Affiliation": "Department of Chemical Sciences, University of Johannesburg, Doornfontein 2028, South Africa."}], "LastName": "Josiah", "ForeName": "Andrea Jess", "Initials": "AJ"}, {"Identifier": ["0000-0001-6701-5547"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant and Soil Sciences, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria 0002, South Africa."}], "LastName": "Twilley", "ForeName": "Danielle", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "DST-CSIR National Centre for Nanostructured Materials, Council for Scientific and Industrial Research, Pretoria 0001, South Africa."}], "LastName": "Pillai", "ForeName": "Sreejarani Kesavan", "Initials": "SK"}, {"Identifier": ["0000-0002-0007-2595"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "DST-CSIR National Centre for Nanostructured Materials, Council for Scientific and Industrial Research, Pretoria 0001, South Africa."}, {"Identifier": [], "Affiliation": "Department of Chemical Sciences, University of Johannesburg, Doornfontein 2028, South Africa."}], "LastName": "Ray", "ForeName": "Suprakas Sinha", "Initials": "SS"}, {"Identifier": ["0000-0002-3242-3476"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant and Soil Sciences, Faculty of Natural and Agricultural Sciences, University of Pretoria, Pretoria 0002, South Africa."}, {"Identifier": [], "Affiliation": "School of Natural Resources, University of Missouri, Columbia, MO 65211, USA."}, {"Identifier": [], "Affiliation": "College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, India."}], "LastName": "Lall", "ForeName": "Namrita", "Initials": "N"}], "GrantList": [{"GrantID": "HGER74p", "Agency": "Council for Scientific and Industrial Research, South Africa", "Country": ""}, {"GrantID": "HGERA8x", "Agency": "Department of Science and Technology", "Country": ""}], "PublicationTypeList": ["Journal Article", "Meta-Analysis", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": [], "DescriptorName": "Biological Variation, Population"}, {"QualifierName": [], "DescriptorName": "Clinical Studies as Topic"}, {"QualifierName": [], "DescriptorName": "Disease Management"}, {"QualifierName": [], "DescriptorName": "Disease Susceptibility"}, {"QualifierName": [], "DescriptorName": "Drug Administration Routes"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Incidence"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Keratinocytes"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Population Surveillance"}, {"QualifierName": ["diagnosis", "drug therapy", "etiology", "metabolism"], "DescriptorName": "Precancerous Conditions"}, {"QualifierName": ["diagnosis", "drug therapy", "etiology", "metabolism"], "DescriptorName": "Skin Neoplasms"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol. 2012;166:1069\u20131080. doi: 10.1111/j.1365-2133.2012.10830.x.", "ArticleIdList": ["10.1111/j.1365-2133.2012.10830.x", "22251204"]}, {"Citation": "Sim\u00f5es M.C.F., Sousa J.J.S., Pais A.A.C.C. Skin cancer and new treatment perspectives: A review. Cancer Lett. 2015;357:8\u201342. doi: 10.1016/j.canlet.2014.11.001.", "ArticleIdList": ["10.1016/j.canlet.2014.11.001", "25444899"]}, {"Citation": "Nehal K.S., Bichakjian C.K. Update on Keratinocyte Carcinomas. N. Engl. J. Med. 2018;379:363\u2013374. doi: 10.1056/NEJMra1708701.", "ArticleIdList": ["10.1056/NEJMra1708701", "30044931"]}, {"Citation": "\u2018Skin Cancer Types|the Woodruff Institute\u2019.  [(accessed on 10 March 2021)]; Available online:  https://www.thewoodruffinstitute.com/skin-cancer-types/"}, {"Citation": "Blanpain C., Fuchs E. Epidermal stem cells of the skin. Annu. Rev. Cell Dev. Biol. 2006;22:339\u2013373. doi: 10.1146/annurev.cellbio.22.010305.104357.", "ArticleIdList": ["10.1146/annurev.cellbio.22.010305.104357", "PMC2405915", "16824012"]}, {"Citation": "Crouch H.E. History of basal cell carcinoma and its treatment. J. R. Soc. Med. 1983;76:302\u2013306. doi: 10.1177/014107688307600413.", "ArticleIdList": ["10.1177/014107688307600413", "PMC1438987", "6341587"]}, {"Citation": "Lever W.F. Pathogenesis of benign tumors of cutaneous appendages and of basal cell epithelioma: I. benign tumors of the cutaneous appendages. Arch. Derm. Syphilol. 1948;57:679\u2013708. doi: 10.1001/archderm.1948.01520170077010.", "ArticleIdList": ["10.1001/archderm.1948.01520170077010", "18886278"]}, {"Citation": "Sellheyer K. Basal cell carcinoma: Cell of origin, cancer stem cell hypothesis and stem cell markers. Br. J. Dermatol. 2011;164:696\u2013711. doi: 10.1111/j.1365-2133.2010.10158.x.", "ArticleIdList": ["10.1111/j.1365-2133.2010.10158.x", "21128907"]}, {"Citation": "Ponten F., Ren Z., Nister M., Westermark B., Ponten J. Epithelial-Stromal Interactions in Basal Cell Cancer: The PDGF System. J. Investig. Dermatol. 1994;102 doi: 10.1111/1523-1747.ep12371787.", "ArticleIdList": ["10.1111/1523-1747.ep12371787", "8120413"]}, {"Citation": "Micke P., Kappert K., Ohshima M., Sundquist C., Scheidl S., Lindahl P., Heldin C.H., Botling J., Ponten F., \u00d6stman A. In situ identification of genes regulated specifically in fibroblasts of human basal cell carcinoma. J. Investig. Dermatol. 2007;127:1516\u20131523. doi: 10.1038/sj.jid.5700714.", "ArticleIdList": ["10.1038/sj.jid.5700714", "17273163"]}, {"Citation": "Kasper M., Jaks V., Hohl D., Toftg\u00e5rd R. Basal cell carcinoma\u2014Molecular biology and potential new therapies. J. Clin. Investig. 2012;122:455\u2013463. doi: 10.1172/JCI58779.", "ArticleIdList": ["10.1172/JCI58779", "PMC3266783", "22293184"]}, {"Citation": "Tan S.T., Ghaznawie M., Heenan P.J., Dosan R. Basal cell carcinoma arises from interfollicular layer of epidermis. J. Oncol. 2018;2018 doi: 10.1155/2018/3098940.", "ArticleIdList": ["10.1155/2018/3098940", "PMC6178174", "30356421"]}, {"Citation": "Kipling M.D., Usherwood R., Varley R. A monstrous growth: An historical note on carcinoma of the scrotum. Br. J. Ind. Med. 1970;27:382\u2013384. doi: 10.1136/oem.27.4.382.", "ArticleIdList": ["10.1136/oem.27.4.382", "PMC1069432", "4922857"]}, {"Citation": "Azike J.E. A Review of the History, Epidemiology and Treatment of Squamous Cell Carcinoma of the Scrotum. Rare Tumors. 2009;1:47\u201349. doi: 10.4081/rt.2009.e17.", "ArticleIdList": ["10.4081/rt.2009.e17", "PMC2994436", "21139888"]}, {"Citation": "Johnson T.M., Rowe D.E., Nelson B.R., Swanson N.A. Squamous cell carcinoma of the skin (excluding lip and oral mucosa) J. Am. Acad. Dermatol. 1992;26:467\u2013484. doi: 10.1016/0190-9622(92)70074-P.", "ArticleIdList": ["10.1016/0190-9622(92)70074-P", "1564155"]}, {"Citation": "Centres for Disease Control and Prevention, \u2018What Is Skin Cancer?|CDC\u2019.  [(accessed on 11 November 2020)]; Available online:  https://www.cdc.gov/cancer/skin/basic_info/what-is-skin-cancer.htm."}, {"Citation": "Yan W., Wistuba I.I., Emmert-Buck M.R., Erickson H.S. Squamous Cell Carcinoma\u2014Similarities and Differences among Anatomical Sites. Am. J. Cancer Res. 2011;1:275\u2013300.", "ArticleIdList": ["PMC3175764", "21938273"]}, {"Citation": "World Health Organization, \u2018Radiation: Ultraviolet (UV) Radiation and Skin Cancer.  [(accessed on 11 November 2020)];2017  Available online:  https://www.who.int/news-room/q-a-detail/ultraviolet-(uv)-radiation-and-skin-cancer."}, {"Citation": "Choquet H., Ashrafzadeh S., Kim Y., Asgari M.M., Jorgenson E. Genetic and environmental factors underlying keratinocyte carcinoma risk. JCI Insight. 2020;5 doi: 10.1172/jci.insight.134783.", "ArticleIdList": ["10.1172/jci.insight.134783", "PMC7259534", "32434987"]}, {"Citation": "Rogers H.W., Weinstock M.A., Feldman S.R., Coldiron B.M. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the us population, 2012. JAMA Dermatol. 2015;151:1081\u20131086. doi: 10.1001/jamadermatol.2015.1187.", "ArticleIdList": ["10.1001/jamadermatol.2015.1187", "25928283"]}, {"Citation": "Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "World Health Organization\u2014International Agency for Research on Cancer, \u2018Cancer Today\u2019.  [(accessed on 10 March 2021)]; Available online:  https://gco.iarc.fr/today/online-analysis-map?v=2020&mode=population&mode_population=continents&population=900&populations=900&key=asr&sex=0&cancer=17&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=0&ages_group%5B%5D=17&nb_items=10&group_cancer=1&include_nmsc=1&include_nmsc_other=1&projection=natural-earth&color_palette=default&map_scale=quantile&map_nb_colors=5&continent=0&show_ranking=0&rotate=%255B10%252C0%255D."}, {"Citation": "Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br. J. Dermatol. 2002;146:1\u20136. doi: 10.1046/j.1365-2133.146.s61.2.x.", "ArticleIdList": ["10.1046/j.1365-2133.146.s61.2.x", "11966724"]}, {"Citation": "Cia\u017ay\u0144ska M., Narbutt J., Wo\u017aniacka A., Lesiak A. Trends in basal cell carcinoma incidence rates: A 16-yearretrospective study of a population in central Poland. Postep. Dermatol. Alergol. 2018;35:47\u201352. doi: 10.5114/ada.2018.73164.", "ArticleIdList": ["10.5114/ada.2018.73164", "PMC5872246", "29599671"]}, {"Citation": "Dessinioti C., Antoniou C., Katsambas A., Stratigos A.J. Basal cell carcinoma: What\u2019s new under the sun. Photochem. Photobiol. 2010;86:481\u2013491. doi: 10.1111/j.1751-1097.2010.00735.x.", "ArticleIdList": ["10.1111/j.1751-1097.2010.00735.x", "20550646"]}, {"Citation": "Apalla Z., Lallas A., Sotiriou E., Lazaridou E., Ioannides D. Epidemiological trends in skin cancer. Dermatol. Pract. Concept. 2017;7:1. doi: 10.5826/dpc.0702a01.", "ArticleIdList": ["10.5826/dpc.0702a01", "PMC5424654", "28515985"]}, {"Citation": "South African National Health Laboratory Service, \u2018National Cancer Registry\u2019.  [(accessed on 11 November 2020)];2016  Available online:  https://cansa.org.za/files/2020/10/NCR_2016_Report_updated_14April2020.pdf."}, {"Citation": "Hannuksela-Svahn A., Pukkala E., Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch. Dermatol. 1999;135:781\u2013786. doi: 10.1001/archderm.135.7.781.", "ArticleIdList": ["10.1001/archderm.135.7.781", "10411152"]}, {"Citation": "Boi S., Cristofolini M., Micciolo R., Polla E., Palma P.D. Epidemiology of Skin Tumors: Data from the Cutaneous Cancer Registry in Trentino, Italy.  [(accessed on 11 November 2020)];J. Cutan. Med. Surg. Inc. Med. Surg. Dermatol. 2020 7:300\u2013305. doi: 10.1007/s10227-002-0135-0. Available online:  https://www.academia.edu/5028523/Epidemiology_of_Skin_Tumors_Data_from_the_Cutaneous_Cancer_Registry_in_Trentino_Italy.", "ArticleIdList": ["10.1007/s10227-002-0135-0", "12879331"]}, {"Citation": "Smoller B.R. Lever\u2019s Histopathology of the Skin, 10th edition. J. Cutan. Pathol. 2009;36:605."}, {"Citation": "Motaparthi K., Kapil J.P., Velazquez E.F. Cutaneous Squamous Cell Carcinoma: Review of the Eighth Edition of the American Joint Committee on Cancer Staging Guidelines, Prognostic Factors, and Histopathologic Variants. Adv. Anat. Pathol. 2017;24:171\u2013194. doi: 10.1097/PAP.0000000000000157.", "ArticleIdList": ["10.1097/PAP.0000000000000157", "28590951"]}, {"Citation": "Baheti A.D., Tirumani S.H., Giardino A., Rosenthal M.H., Tirumani H., Krajewski K., Ramaiya N.H. Basal Cell Carcinoma: A Comprehensive Review for the Radiologist. Am. J. Roentgenol. 2015;204:W132\u2013W140. doi: 10.2214/AJR.14.13160.", "ArticleIdList": ["10.2214/AJR.14.13160", "25615773"]}, {"Citation": "D\u0119bski T., Lembas L., Jethon J. In: Basal Cell Carcinoma, Current Concepts in Plastic Surgery. Agullo F., editor. InTech; London, UK: 2012."}, {"Citation": "Edge S., Byrd D.R., Compton C.C., Fritz A.G., Greene F., Trotti A. AJCC Cancer Staging Handbook\u2014From the AJCC Cancer Staging Manual|Stephen Edge|Springer.  [(accessed on 27 March 2019)];2010  Available online:  https://www.springer.com/la/book/9780387884424."}, {"Citation": "Fahradyan A., Howell A., Wolfswinkel E., Tsuha M., Sheth P., Wong A. Updates on the Management of Non-Melanoma Skin Cancer (NMSC) Healthcare. 2017;5:82. doi: 10.3390/healthcare5040082.", "ArticleIdList": ["10.3390/healthcare5040082", "PMC5746716", "29104226"]}, {"Citation": "Dourmishev L., Rusinova D., Botev I. Clinical variants, stages, and management of basal cell carcinoma. Indian Dermatol. Online J. 2013;4:12. doi: 10.4103/2229-5178.105456.", "ArticleIdList": ["10.4103/2229-5178.105456", "PMC3573444", "23439912"]}, {"Citation": "McDaniel B., Bermudez R. Epitheliomas, Basal Cell. StatPearls. 2018;2:161\u2013168."}, {"Citation": "Yanofsky V.R., Mercer S.E., Phelps R.G. Histopathological Variants of Cutaneous Squamous Cell Carcinoma: A Review. J. Skin Cancer. 2011;2011:1\u201313. doi: 10.1155/2011/210813.", "ArticleIdList": ["10.1155/2011/210813", "PMC3018652", "21234325"]}, {"Citation": "Parekh V., Seykora J.T. Cutaneous Squamous Cell Carcinoma. Clin. Lab. Med. 2017;37:503\u2013525. doi: 10.1016/j.cll.2017.06.003.", "ArticleIdList": ["10.1016/j.cll.2017.06.003", "28802498"]}, {"Citation": "McKee P.H., Calonje E., Granter S.R. Pathology of the Skin with Clinical Correlations. 3rd ed. Mosby Ltd.; St. Louis, MO, USA: 2005."}, {"Citation": "\u015eahin N., Bozda\u01e7 Z., Erkili\u00e7 S., Aydin N.E., \u015eener S. Histopathological subtyping of actinic keratosis and it\u2019s coexistence with nonmelanotic skin cancers in Gaziantep and Malatya regions. Turkderm Turk. Arch. Dematol. Venereol. 2016;50:103\u2013108. doi: 10.4274/turkderm.53765.", "ArticleIdList": ["10.4274/turkderm.53765"]}, {"Citation": "Abudu B., Calame A., Cohen P.R. Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma. Cureus. 2019;11 doi: 10.7759/cureus.4721.", "ArticleIdList": ["10.7759/cureus.4721", "PMC6650181", "31355081"]}, {"Citation": "Maor D., Ondhia C., Yu L.L., Chan J.J. Lichenoid keratosis is frequently misdiagnosed as basal cell carcinoma. Clin. Exp. Dermatol. 2017;42:663\u2013666. doi: 10.1111/ced.13178.", "ArticleIdList": ["10.1111/ced.13178", "28636260"]}, {"Citation": "Goldberg L.H., Joseph A.K., Tschen J.A. Proliferative actinic keratosis. Int. J. Dermatol. 1994;33:341\u2013345. doi: 10.1111/j.1365-4362.1994.tb01065.x.", "ArticleIdList": ["10.1111/j.1365-4362.1994.tb01065.x", "8039973"]}, {"Citation": "Billano R.A., Little W.P. Hypertrophic actinic keratosis. J. Am. Acad. Dermatol. 1982;7:484\u2013489. doi: 10.1016/S0190-9622(82)80251-X.", "ArticleIdList": ["10.1016/S0190-9622(82)80251-X", "7142459"]}, {"Citation": "Person J.R. An actinic keratosis is neither malignant nor premalignant: It is an initiated tumor. J. Am. Acad. Dermatol. 2003;48:637\u2013638. doi: 10.1067/mjd.2003.14.", "ArticleIdList": ["10.1067/mjd.2003.14", "12664040"]}, {"Citation": "Carapeto F.J., Garc\u00eda-P\u00e9rez A. Acantholytic Keratosis. Dermatology. 1974;148:233\u2013239. doi: 10.1159/000251644.", "ArticleIdList": ["10.1159/000251644", "4850380"]}, {"Citation": "Kim S.M., Myoung H., Eo M.Y., Cho Y.J., Lee S.K. Proper management of suspicious actinic cheilitis. Maxillofac. Plast. Reconstr. Surg. 2019;41:15. doi: 10.1186/s40902-019-0198-0.", "ArticleIdList": ["10.1186/s40902-019-0198-0", "PMC6453983", "31032237"]}, {"Citation": "Copcu E., Sivrioglu N., Culhaci N. Cutaneous horns: Are these lesions as innocent as they seem to be? World J. Surg. Oncol. 2004;2:18. doi: 10.1186/1477-7819-2-18.", "ArticleIdList": ["10.1186/1477-7819-2-18", "PMC421749", "15176977"]}, {"Citation": "Ulrich M., Stockfleth E., Roewert-Huber J., Astner S. Noninvasive diagnostic tools for nonmelanoma skin cancer. Br. J. Dermatol. 2007;157:56\u201358. doi: 10.1111/j.1365-2133.2007.08275.x.", "ArticleIdList": ["10.1111/j.1365-2133.2007.08275.x", "18067634"]}, {"Citation": "Hawrot A., Alam M., Ratner D. Squamous cell carcinoma. Curr. Probl. Dermatol. 2003;15:91\u2013133. doi: 10.1016/S1040-0486(03)00005-X.", "ArticleIdList": ["10.1016/S1040-0486(03)00005-X"]}, {"Citation": "Ogawa T., Kiuru M., Konia T.H., Fung M.A. Acantholytic squamous cell carcinoma is usually associated with hair follicles, not acantholytic actinic keratosis, and is not \u201chigh risk\u201d: Diagnosis, management, and clinical outcomes in a series of 115 cases. J. Am. Acad. Dermatol. 2017;76:327\u2013333. doi: 10.1016/j.jaad.2016.09.024.", "ArticleIdList": ["10.1016/j.jaad.2016.09.024", "PMC5319832", "27889291"]}, {"Citation": "Nappi O., Pettinato G., Wick M.R. Adenoid (acantholytic) squamous cell carcinoma of the skin. J. Cutan. Pathol. 1989;16:114\u2013121. doi: 10.1111/j.1600-0560.1989.tb00024.x.", "ArticleIdList": ["10.1111/j.1600-0560.1989.tb00024.x", "2768593"]}, {"Citation": "Silvis N.G., Swanson P.E., Manivel J.C., Kaye V.N., Wick M.R. Spindle-cell and pleomorphic neoplasms of the skin. A clinicopathologic and immunohistochemical study of 30 cases, with emphasis on \u201catypical fibroxanthomas\u201d. Am. J. Dermatopathol. 1988;10:9\u201319. doi: 10.1097/00000372-198802000-00002.", "ArticleIdList": ["10.1097/00000372-198802000-00002", "3177827"]}, {"Citation": "Schwartz R.A. Verrucous carcinoma of the skin and mucosa. J. Am. Acad. Dermatol. 1995;32:1\u201321. doi: 10.1016/0190-9622(95)90177-9.", "ArticleIdList": ["10.1016/0190-9622(95)90177-9", "7822496"]}, {"Citation": "Kuo T. Clear cell carcinoma of the skin. A variant of the squamous cell carcinoma that simulates sebaceous carcinoma. Am. J. Surg. Pathol. 1980;4:573\u2013583. doi: 10.1097/00000478-198012000-00008.", "ArticleIdList": ["10.1097/00000478-198012000-00008", "6163367"]}, {"Citation": "Ko C.J., McNiff J.M., Glusac E.J. Squamous cell carcinomas with single cell infiltration: A potential diagnostic pitfall and the utility of MNF116 and p63. J. Cutan. Pathol. 2008;35:353\u2013357. doi: 10.1111/j.1600-0560.2007.00808.x.", "ArticleIdList": ["10.1111/j.1600-0560.2007.00808.x", "18333895"]}, {"Citation": "Weber F., Bauer J.W., Sepp N., H\u00f6gler W., Salmhofer W., Hintner H., Fritsch P. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa. Acta Derm. Venereol. 2001;81:189\u2013192. doi: 10.1080/000155501750376285.", "ArticleIdList": ["10.1080/000155501750376285", "11558875"]}, {"Citation": "Sabin S.R., Goldstein G., Rosenthal H.G., Haynes K.K. Aggressive Squamous Cell Carcinoma Originating as a Marjolin\u2019s Ulcer. Dermatol. Surg. 2004;30:229\u2013230. doi: 10.1111/j.1524-4725.2004.30072.x.", "ArticleIdList": ["10.1111/j.1524-4725.2004.30072.x", "14756658"]}, {"Citation": "Burton K.A., Ashack K.A., Khachemoune A. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease. Am. J. Clin. Dermatol. 2016;17:491\u2013508. doi: 10.1007/s40257-016-0207-3.", "ArticleIdList": ["10.1007/s40257-016-0207-3", "27358187"]}, {"Citation": "Clayman G.L., Lee J.J., Holsinger F.C., Zhou X., Duvic M., El-Naggar A.K., Prieto V.G., Altamirano E., Tucker S.L., Strom S.S., et al. Mortality risk from squamous cell skin cancer. J. Clin. Oncol. 2005;23:759\u2013765. doi: 10.1200/JCO.2005.02.155.", "ArticleIdList": ["10.1200/JCO.2005.02.155", "15681519"]}, {"Citation": "Rowe D.E., Carroll R.J., Day C.L. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection. J. Am. Acad. Dermatol. 1992;26:976\u2013990. doi: 10.1016/0190-9622(92)70144-5.", "ArticleIdList": ["10.1016/0190-9622(92)70144-5", "1607418"]}, {"Citation": "Brunner M., Veness M.J., Ch\u2019Ng S., Elliott M., Clark J.R. Distant metastases from cutaneous squamous cell carcinoma-analysis of AJCC stage IV. Head Neck. 2013;35:72\u201375. doi: 10.1002/hed.22913.", "ArticleIdList": ["10.1002/hed.22913", "22266877"]}, {"Citation": "Bonerandi J.J., Beauvillain C., Caquant L., Chassagne J.F., Chaussade V., Clav\u00e8re P., Desouches C., Garnier F., Grolleau J.L., Grossin M., et al. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J. Eur. Acad. Dermatol. Venereol. 2011;25:1\u201351. doi: 10.1111/j.1468-3083.2011.04296.x.", "ArticleIdList": ["10.1111/j.1468-3083.2011.04296.x", "22070399"]}, {"Citation": "Lazarus H.M., Herzig R.H., Bornstein R., Laipply T.C. Metastatic squamous cell carcinoma of the skin. J. Natl. Med. Assoc. 1980;72:1196\u20131199.", "ArticleIdList": ["PMC2609730", "7310907"]}, {"Citation": "Piva De Freitas P., Senna C.G., Tabai M., Chone C.T., Altemani A. Metastatic Basal Cell Carcinoma: A Rare Manifestation of a Common Disease. Case Rep. Med. 2017;2017 doi: 10.1155/2017/8929745.", "ArticleIdList": ["10.1155/2017/8929745", "PMC5723960", "29279714"]}, {"Citation": "Vu A., Laub D., Jr. Basal Cell Carcinoma. InTech; London, UK: 2012. Metastatic Basal Cell Carcinoma."}, {"Citation": "Gordon R. Skin cancer: An overview of epidemiology and risk factors. Semin. Oncol. Nurs. 2013;29:160\u2013169. doi: 10.1016/j.soncn.2013.06.002.", "ArticleIdList": ["10.1016/j.soncn.2013.06.002", "23958214"]}, {"Citation": "Xiang F., Lucas R., Hales S., Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012 empirical relationships. JAMA Dermatol. 2014;150:1063\u20131071. doi: 10.1001/jamadermatol.2014.762.", "ArticleIdList": ["10.1001/jamadermatol.2014.762", "25103031"]}, {"Citation": "Kim I.Y., He Y.Y. Ultraviolet radiation-induced non-melanoma skin cancer: Regulation of DNA damage repair and inflammation. Genes Dis. 2014;1:188\u2013198.", "ArticleIdList": ["PMC4307792", "25642450"]}, {"Citation": "Tran T.N.T., Schulman J., Fisher D.E. UV and pigmentation: Molecular mechanisms and social controversies. Pigment. Cell Melanoma Res. 2008;21:509\u2013516.", "ArticleIdList": ["PMC2733367", "18821855"]}, {"Citation": "Grossman D. The Molecular Basis of Nonmelanoma Skin Cancer. Arch. Dermatol. 1997;133:1263.", "ArticleIdList": ["9382565"]}, {"Citation": "Ibrahim S.F., Brown M.D. Tanning and Cutaneous Malignancy. Dermatol. Surg. 2008;34:460\u2013474.", "ArticleIdList": ["18248469"]}, {"Citation": "Latonen L., Laiho M. Cellular UV damage responses\u2014Functions of tumor suppressor p53. Biochim. Biophys. Acta Rev. Cancer. 2005;1755:71\u201389.", "ArticleIdList": ["15921859"]}, {"Citation": "Boukamp P. Non-melanoma skin cancer: What drives tumor development and progression? Carcinogenesis. 2005;26:1657\u20131667.", "ArticleIdList": ["15905207"]}, {"Citation": "Marks R. The epidemiology of non-melanoma skin cancer: Who, why and what can we do about it. J. Dermatol. 1995;22:853\u2013857. doi: 10.1111/j.1346-8138.1995.tb03935.x.", "ArticleIdList": ["10.1111/j.1346-8138.1995.tb03935.x", "8557858"]}, {"Citation": "Soehnge H., Ouhtit A., Ananthaswamy O.N. Mechanisms of induction of skin cancer by UV radiation. Front. Biosci. 1997;2 doi: 10.2741/a211.", "ArticleIdList": ["10.2741/a211", "9343491"]}, {"Citation": "Kooy A.J.W., Prens E.P., Van Heuklelum A., Vuzevski V.D., Van Joost T., Tank B. Interferon-\u03b3-induced ICAM-1 and CD40 expression, complete lack of HLA- DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: A possible role for interleukin-10? J. Pathol. 1999;187:351\u2013357.", "ArticleIdList": ["10398091"]}, {"Citation": "El Ghissassi F., Baan R., Straif K., Grosse Y., Secretan B., Bouvard V., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., et al. Special Report: Policy A Review of Human Carcinogens-Part. D: Radiation. Lancet. 2009;10:751\u2013752. doi: 10.1016/S1470-2045(09)70213-X.", "ArticleIdList": ["10.1016/S1470-2045(09)70213-X", "19655431"]}, {"Citation": "Gerber B., Mathys P., Moser M., Bressoud D., Braun-Fahrl\u00e4nder C. Ultraviolet Emission Spectra of Sunbeds. Photochem. Photobiol. 2002;76:664. doi: 10.1562/0031-8655(2002)076<0664:UESOS>2.0.CO;2.", "ArticleIdList": ["10.1562/0031-8655(2002)076<0664:UESOS>2.0.CO;2", "12511047"]}, {"Citation": "Wehner M.R., Shive M.L., Chren M.M., Han J., Qureshi A.A., Linos E. Indoor tanning and non-melanoma skin cancer: Systematic review and meta-analysis. BMJ. 2012;345:e5909. doi: 10.1136/bmj.e5909.", "ArticleIdList": ["10.1136/bmj.e5909", "PMC3462818", "23033409"]}, {"Citation": "Karagas M.R., Nelson H.H., Zens M.S., Linet M., Stukel T.A., Spencer S., Applebaum K.M., Mott L., Mabuchi K. Squamous cell and basal cell carcinoma of the skin in relation to radiation therapy and potential modification of risk by sun exposure. Epidemiology. 2007;18:776\u2013784. doi: 10.1097/EDE.0b013e3181567ebe.", "ArticleIdList": ["10.1097/EDE.0b013e3181567ebe", "17917604"]}, {"Citation": "Ryan J.L. Ionizing radiation: The good, the bad, and the ugly. J. Investig. Dermatol. 2012;132:985\u2013993. doi: 10.1038/jid.2011.411.", "ArticleIdList": ["10.1038/jid.2011.411", "PMC3779131", "22217743"]}, {"Citation": "Hunt K.M., Srivastava R.K., Athar M. Handbook of Arsenic Toxicology. Elsevier Inc.; Amsterdam, The Netherlands: 2015. Cutaneous Toxicology of Arsenic; pp. 301\u2013314."}, {"Citation": "Leus A.J.G., Frie M., Haisma M.S., Terra J.B., Plaat B.E.C., Steenbakkers R.J.H.M., Halmos G.B., R\u00e1cz E. Treatment of keratinocyte carcinoma in elderly patients\u2014a review of the current literature. J. Eur. Acad. Dermatol. Venereol. 2020:jdv.16268. doi: 10.1111/jdv.16268.", "ArticleIdList": ["10.1111/jdv.16268", "PMC7496368", "32030838"]}, {"Citation": "Malaguarnera G., Giordano M., Cappellani A., Berretta M., Malaguarnera M., Perrotta R. Skin Cancers in Elderly Patients. Anticancer Agents Med. Chem. 2013;13:1406\u20131411. doi: 10.2174/18715206113136660349.", "ArticleIdList": ["10.2174/18715206113136660349", "24102278"]}, {"Citation": "Perrotta R.E., Giordano M., Malaguarnera M. Non-melanoma skin cancers in elderly patients. Crit. Rev. Oncol. Hematol. 2011;80:474\u2013480. doi: 10.1016/j.critrevonc.2011.04.011.", "ArticleIdList": ["10.1016/j.critrevonc.2011.04.011", "21602051"]}, {"Citation": "Brenner M., Hearing V.J. The protective role of melanin against UV damage in human skin. Photochem. Photobiol. 2008;84:539\u2013549. doi: 10.1111/j.1751-1097.2007.00226.x.", "ArticleIdList": ["10.1111/j.1751-1097.2007.00226.x", "PMC2671032", "18435612"]}, {"Citation": "Gloster H.M., Neal K. Skin cancer in skin of color. J. Am. Acad. Dermatol. 2006;55:741\u2013760. doi: 10.1016/j.jaad.2005.08.063.", "ArticleIdList": ["10.1016/j.jaad.2005.08.063", "17052479"]}, {"Citation": "Nagarajan P., Asgari M.M., Green A.C., Guhan S.M., Arron S.T., Proby C.M., Rollison D.E., Harwood C.A., Toland A.E. Keratinocyte carcinomas: Current concepts and future research priorities. Clin. Cancer Res. 2019;25:2379\u20132391. doi: 10.1158/1078-0432.CCR-18-1122.", "ArticleIdList": ["10.1158/1078-0432.CCR-18-1122", "PMC6467785", "30523023"]}, {"Citation": "Micali G., Lacarrubba F., Nasca M.R., Ferraro S., Schwartz R.A. Topical pharmacotherapy for skin cancer: Part II. Clinical applications. J. Am. Acad. Dermatol. 2014;70:e1\u2013e979. doi: 10.1016/j.jaad.2013.12.037.", "ArticleIdList": ["10.1016/j.jaad.2013.12.037", "24831325"]}, {"Citation": "Lanoue J., Goldenberg G. Basal cell carcinoma: A comprehensive review of existing and emerging nonsurgical therapies. J. Clin. Aesthet. Dermatol. 2016;9:26\u201336.", "ArticleIdList": ["PMC4928477", "27386043"]}, {"Citation": "Eaglstein W.H., Weinstein G.D., Frost P. Fluorouracil: Mechanism of Action in Human Skin and Actinic Keratoses: I. Effect on DNA Synthesis in Vivo. Arch. Dermatol. 1970;101:132\u2013139. doi: 10.1001/archderm.1970.04000020002002.", "ArticleIdList": ["10.1001/archderm.1970.04000020002002", "5413250"]}, {"Citation": "Longley D.B., Harkin D.P., Johnston P.G. 5-Fluorouracil: Mechanisms of action and clinical strategies. Nat. Rev. Cancer. 2003;3:330\u2013338. doi: 10.1038/nrc1074.", "ArticleIdList": ["10.1038/nrc1074", "12724731"]}, {"Citation": "How to Use Fluorouracil and Imiquimod for Non-Melanoma Skin Cancer in a General Practice Setting.  [(accessed on 28 July 2018)];2017  Available online:  https://bpac.org.nz/2017/skin-cancer.aspx."}, {"Citation": "Bahner J.D., Bordeaux J.S. Non-melanoma skin cancers: Photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin. Dermatol. 2013;31:792\u2013798. doi: 10.1016/j.clindermatol.2013.08.020.", "ArticleIdList": ["10.1016/j.clindermatol.2013.08.020", "24160289"]}, {"Citation": "Metterle L., Nelson C., Patel N. Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review. J. Am. Acad. Dermatol. 2016;74:552\u2013557. doi: 10.1016/j.jaad.2015.09.040.", "ArticleIdList": ["10.1016/j.jaad.2015.09.040", "26577512"]}, {"Citation": "Chosidow O., Dummer R. Imiquimod: Mode of action and therapeutic potential. Acta Derm. Venereol. Suppl. (Stockh.) 2003:8\u201311. doi: 10.1080/03658340310011889.", "ArticleIdList": ["10.1080/03658340310011889", "14606276"]}, {"Citation": "Rosen R.H., Gupta A.K., Tyring S.K. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: Rapid lesion necrosis followed by lesion-specific immune response. J. Am. Acad. Dermatol. 2012;66:486\u2013493. doi: 10.1016/j.jaad.2010.12.038.", "ArticleIdList": ["10.1016/j.jaad.2010.12.038", "22055282"]}, {"Citation": "Doan H.Q., Gulati N., Levis W.R. Ingenol mebutate: Potential for further development of cancer immunotherapy. J. Drugs Dermatol. 2012;11:1156\u20131157.", "ArticleIdList": ["PMC4283592", "23134979"]}, {"Citation": "Lebwohl M., Sohn A. Ingenol mebutate (ingenol 3-angelate, PEP005): Focus on its uses in the treatment of nonmelanoma skin cancer. Expert Rev. Dermatol. 2012;7:121\u2013128. doi: 10.1586/edm.12.13.", "ArticleIdList": ["10.1586/edm.12.13"]}, {"Citation": "Cozzi S.J., Le T.T., Ogbourne S.M., James C., Suhrbier A. Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice. Arch. Dermatol. Res. 2013;305:79\u201383. doi: 10.1007/s00403-012-1270-0.", "ArticleIdList": ["10.1007/s00403-012-1270-0", "PMC3535356", "22871992"]}, {"Citation": "Moreno Romero J.A., Campoy A., Perez N., Garcia F., Grimalt R. Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: Report of two cases. Br. J. Dermatol. 2015;173:1514\u20131517. doi: 10.1111/bjd.14054.", "ArticleIdList": ["10.1111/bjd.14054", "26227007"]}, {"Citation": "Dolmans D.E.J.G.J., Fukumura D., Jain R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer. 2003;3:380\u2013387. doi: 10.1038/nrc1071.", "ArticleIdList": ["10.1038/nrc1071", "12724736"]}, {"Citation": "Vrouenraets M.B., Visser G.W.M., Snow G.B., Van Dongen G.A.M.S. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res. 2003;23:505\u2013522.", "ArticleIdList": ["12680139"]}, {"Citation": "Cohen D.K., Lee P.K. Photodynamic therapy for non-melanoma skin cancers. Cancers. 2016;8:90. doi: 10.3390/cancers8100090.", "ArticleIdList": ["10.3390/cancers8100090", "PMC5082380", "27782043"]}, {"Citation": "Matei C., Tampa M., Poteca T., Panea-Paunica G., Georgescu S.R., Ion R.M., Popescu S.M., Giurcaneanu C. Photodynamic therapy in the treatment of basal cell carcinoma. J. Med. Life. 2013;6:50\u201354.", "ArticleIdList": ["PMC3624646", "23599819"]}, {"Citation": "Kang Z., Zhang J., Zhou J., Qi Q., Du G., Chen J. Recent advances in microbial production of \u03b4-aminolevulinic acid and vitamin B12. Biotechnol. Adv. 2012;30:1533\u20131542. doi: 10.1016/j.biotechadv.2012.04.003.", "ArticleIdList": ["10.1016/j.biotechadv.2012.04.003", "22537876"]}, {"Citation": "Cullen J.K., Simmons J.L., Parsons P.G., Boyle G.M. Topical treatments for skin cancer. Adv. Drug Deliv. Rev. 2020;153:54\u201364. doi: 10.1016/j.addr.2019.11.002.", "ArticleIdList": ["10.1016/j.addr.2019.11.002", "31705912"]}, {"Citation": "Christensen E., M\u00f8rk C., Skogvoll E. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: A prospective, clinical and histological 10-year follow-up study. Br. J. Dermatol. 2012;166 doi: 10.1111/j.1365-2133.2012.10878.x.", "ArticleIdList": ["10.1111/j.1365-2133.2012.10878.x", "22309486"]}, {"Citation": "Ahmadi S., McCarron P.A., Donnelly R.F., Woolfson A.D., McKenna K. Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: A pilot study. Exp. Dermatol. 2004;13 doi: 10.1111/j.0906-6705.2004.00181.x.", "ArticleIdList": ["10.1111/j.0906-6705.2004.00181.x", "15217365"]}, {"Citation": "Jansen M.H.E., Mosterd K., Arits A.H.M.M., Roozeboom M.H., Sommer A., Essers B.A.B., van Pelt H.P.A., Quaedvlieg P.J.F., Steijlen P.M., Nelemans P.J., et al. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma. J. Investig. Dermatol. 2018;138:527\u2013533. doi: 10.1016/j.jid.2017.09.033.", "ArticleIdList": ["10.1016/j.jid.2017.09.033", "29045820"]}, {"Citation": "Tschen E.H., Wong D.S., Pariser D.M., Dunlap F.E., Houlihan A., Ferdon M.B. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: Phase IV multicentre clinical trial with 12-month follow up. Br. J. Dermatol. 2006;155 doi: 10.1111/j.1365-2133.2006.07520.x.", "ArticleIdList": ["10.1111/j.1365-2133.2006.07520.x", "17107399"]}, {"Citation": "Peris K., Fargnoli M.C., Chimenti S. Preliminary Observations on the Use of Topical Tazarotene to Treat Basal-Cell Carcinoma. N. Engl. J. Med. 1999;341:1767\u20131768. doi: 10.1056/NEJM199912023412312.", "ArticleIdList": ["10.1056/NEJM199912023412312", "10610445"]}, {"Citation": "Bardazzi F., Bianchi F., Parente G., Guareschi E., Landi C. A pilot study on the use of topical tazarotene to treat squamous cell carcinoma in situ. J. Am. Acad. Dermatol. 2005;52:1102\u20131104. doi: 10.1016/j.jaad.2003.07.003.", "ArticleIdList": ["10.1016/j.jaad.2003.07.003", "15928641"]}, {"Citation": "Bianchi L., Orlandi A., Campione E., Angeloni C., Costanzo A., Spagnoli L.G., Chimenti S. Topical treatment of basal cell carcinoma with tazarotene: A clinicopathological study on a large series of cases. Br. J. Dermatol. 2004;151:148\u2013156. doi: 10.1111/j.1365-2133.2004.06044.x.", "ArticleIdList": ["10.1111/j.1365-2133.2004.06044.x", "15270884"]}, {"Citation": "Ramadon D., McCrudden M.T.C., Courtenay A.J., Donnelly R.F. Enhancement strategies for transdermal drug delivery systems: Current trends and applications. Drug Deliv. Transl. Res. 2021:1\u201334. doi: 10.1007/s13346-021-00909-6.", "ArticleIdList": ["10.1007/s13346-021-00909-6", "PMC7817074", "33474709"]}, {"Citation": "Zeb A., Arif S.T., Malik M., Shah F.A., Din F.U., Qureshi O.S., Lee E.S., Lee G.Y., Kim J.K. Potential of nanoparticulate carriers for improved drug delivery via skin. J. Pharm. Investig. 2019;49:485\u2013517. doi: 10.1007/s40005-018-00418-8.", "ArticleIdList": ["10.1007/s40005-018-00418-8"]}, {"Citation": "Akhtar N., Singh V., Yusuf M., Khan R.A., Khan R.A. Non-invasive drug delivery technology: Development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomed. Tech. 2020;65:243\u2013272. doi: 10.1515/bmt-2019-0019.", "ArticleIdList": ["10.1515/bmt-2019-0019", "31926064"]}, {"Citation": "Yavuz H., \u00c7etin K., Akg\u00f6n\u00fcll\u00fc S., Battal D., Denizli A. Design and Development of New Nanocarriers. Elsevier; Amsterdam, The Netherlands: 2018. Therapeutic protein and drug imprinted nanostructures as controlled delivery tools; pp. 439\u2013473."}, {"Citation": "Benson H.A.E., Grice J.E., Mohammed Y., Namjoshi S., Roberts M.S. Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies. Curr. Drug Deliv. 2019;16:444\u2013460. doi: 10.2174/1567201816666190201143457.", "ArticleIdList": ["10.2174/1567201816666190201143457", "PMC6637104", "30714524"]}, {"Citation": "Dianzani C., Zara G.P., Maina G., Pettazzoni P., Pizzimenti S., Rossi F., Gigliotti C.L., Ciamporcero E.S., Daga M., Barrera G. Drug delivery nanoparticles in skin cancers. Biomed. Res. Int. 2014;2014 doi: 10.1155/2014/895986.", "ArticleIdList": ["10.1155/2014/895986", "PMC4102061", "25101298"]}, {"Citation": "Alkilani A.Z., McCrudden M.T.C., Donnelly R.F. Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7:438\u2013470. doi: 10.3390/pharmaceutics7040438.", "ArticleIdList": ["10.3390/pharmaceutics7040438", "PMC4695828", "26506371"]}, {"Citation": "Tanwar H., Sachdeva R. Transdermal Drug Delivery System: A Review. Int. J. Pharm. Sci. Res. 2016;7:2274\u20132290."}, {"Citation": "Prow T.W., Grice J.E., Lin L.L., Faye R., Butler M., Becker W., Wurm E.M.T., Yoong C., Robertson T.A., Soyer H.P., et al. Nanoparticles and microparticles for skin drug delivery. Adv. Drug Deliv. Rev. 2011;63:470\u2013491. doi: 10.1016/j.addr.2011.01.012.", "ArticleIdList": ["10.1016/j.addr.2011.01.012", "21315122"]}, {"Citation": "Delouise L.A. Applications of nanotechnology in dermatology. J. Investig. Dermatol. 2012;132:964\u2013975. doi: 10.1038/jid.2011.425.", "ArticleIdList": ["10.1038/jid.2011.425", "PMC4066738", "22217738"]}, {"Citation": "Jiang T., Xu G., Chen G., Zheng Y., He B., Gu Z. Progress in transdermal drug delivery systems for cancer therapy. Nano Res. 2020;13:1810\u20131824. doi: 10.1007/s12274-020-2664-5.", "ArticleIdList": ["10.1007/s12274-020-2664-5"]}, {"Citation": "Roy N., Agrawal M., Chaudhary S., Tirkey V., Dhwaj A., Mishra N. Review article on permeation enhancers: A major breakthrough in drug delivery technology. Int. J. Pharm. Sci. Res. 2017;8:1001."}, {"Citation": "Fleury S., Vianna Lopez R.F. Skin Cancers\u2014Risk Factors, Prevention and Therapy. InTech; Rijeka, Croatia: 2011. Topical Administration of Anticancer Drugs for Skin Cancer Treatment."}, {"Citation": "Moses M.A., Brem H., Langer R. Advancing the field of drug delivery: Taking aim at cancer. Cancer Cell. 2003;4:337\u2013341. doi: 10.1016/S1535-6108(03)00276-9.", "ArticleIdList": ["10.1016/S1535-6108(03)00276-9", "14667500"]}, {"Citation": "Hussain A., Samad A., Ramzan M., Ahsan M.N., Ur Rehman Z., Ahmad F.J. Elastic liposome-based gel for topical delivery of 5-fluorouracil: In vitro and in vivo investigation. Drug Deliv. 2016;23:1115\u20131129. doi: 10.3109/10717544.2014.976891.", "ArticleIdList": ["10.3109/10717544.2014.976891", "25379805"]}, {"Citation": "Lin C.H., Al-Suwayeh S.A., Hung C.F., Chen C.C., Fang J.Y. Camptothecin-loaded liposomes with \u03b1-melanocyte-stimulating hormone enhance cytotoxicity toward and cellular uptake by melanomas: An application of nanomedicine on natural product. J. Tradit. Complement. Med. 2013;3:102\u2013109. doi: 10.4103/2225-4110.110423.", "ArticleIdList": ["10.4103/2225-4110.110423", "PMC3924967", "24716164"]}, {"Citation": "Jose A., Labala S., Venuganti V.V.K. Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer. J. Drug Target. 2017;25:330\u2013341. doi: 10.1080/1061186X.2016.1258567.", "ArticleIdList": ["10.1080/1061186X.2016.1258567", "27819148"]}, {"Citation": "Tupal A., Sabzichi M., Ramezani F., Kouhsoltani M., Hamishehkar H. Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer. J. Microencapsul. 2016;33:372\u2013380. doi: 10.1080/02652048.2016.1200150.", "ArticleIdList": ["10.1080/02652048.2016.1200150", "27338131"]}, {"Citation": "Khallaf R.A., Salem H.F., Abdelbary A. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment. Drug Deliv. 2016;23:3452\u20133460. doi: 10.1080/10717544.2016.1194498.", "ArticleIdList": ["10.1080/10717544.2016.1194498", "27240935"]}, {"Citation": "Sabri A., Ogilvie J., McKenna J., Segal J., Scurr D., Marlow M. Intradermal Delivery of an Immunomodulator for Basal Cell Carcinoma; Expanding the Mechanistic Insight into Solid Microneedle-Enhanced Delivery of Hydrophobic Molecules. Mol. Pharm. 2020;17:2925\u20132937. doi: 10.1021/acs.molpharmaceut.0c00347.", "ArticleIdList": ["10.1021/acs.molpharmaceut.0c00347", "32510228"]}, {"Citation": "Seo H.W., Kim D.Y., Kwon D.Y., Kwon J.S., Jin L.M., Lee B., Kim J.H., Min B.H., Kim M.S. Injectable intratumoral hydrogel as 5-fluorouracil drug depot. Biomaterials. 2013;34 doi: 10.1016/j.biomaterials.2013.01.006.", "ArticleIdList": ["10.1016/j.biomaterials.2013.01.006", "23343635"]}, {"Citation": "Ma L., Wang X., Wu J., Zhang D., Zhang L., Song X., Hong H., He C., Mo X., Wu S., et al. Polyethylenimine and sodium cholate-modified ethosomes complex as multidrug carriers for the treatment of melanoma through transdermal delivery. Nanomedicine. 2019;14:2395\u20132408. doi: 10.2217/nnm-2018-0398.", "ArticleIdList": ["10.2217/nnm-2018-0398", "31456475"]}, {"Citation": "Ijaz S., Akhtar N., Khan M.S., Hameed A., Irfan M., Arshad M.A., Ali S., Asrar M. Plant derived anticancer agents: A green approach towards skin cancers. Biomed. Pharmacother. 2018;103:1643\u20131651. doi: 10.1016/j.biopha.2018.04.113.", "ArticleIdList": ["10.1016/j.biopha.2018.04.113", "29864953"]}, {"Citation": "Khazir J., Mir B.A., Pilcher L., Riley D.L. Role of plants in anticancer drug discovery. Phytochem. Lett. 2014;7:173\u2013181. doi: 10.1016/j.phytol.2013.11.010.", "ArticleIdList": ["10.1016/j.phytol.2013.11.010"]}, {"Citation": "Anastyuk S.D., Shevchenko N.M., Usoltseva (Menshova) R.V., Silchenko A.S., Zadorozhny P.A., Dmitrenok P.S., Ermakova S.P. Structural features and anticancer activity in vitro of fucoidan derivatives from brown alga Saccharina cichorioides. Carbohydr. Polym. 2017;157:1503\u20131510. doi: 10.1016/j.carbpol.2016.11.031.", "ArticleIdList": ["10.1016/j.carbpol.2016.11.031", "27987862"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Penta D., Somashekar B.S., Meeran S.M. Epigenetics of skin cancer: Interventions by selected bioactive phytochemicals. Photodermatol. Photoimmunol. Photomed. 2018;34:42\u201349. doi: 10.1111/phpp.12353.", "ArticleIdList": ["10.1111/phpp.12353", "28976029"]}, {"Citation": "Iqbal J., Abbasi B.A., Ahmad R., Batool R., Mahmood T., Ali B., Khalil A.T., Kanwal S., Afzal Shah S., Alam M.M., et al. Potential phytochemicals in the fight against skin cancer: Current landscape and future perspectives. Biomed. Pharmacother. 2019;109:1381\u20131393. doi: 10.1016/j.biopha.2018.10.107.", "ArticleIdList": ["10.1016/j.biopha.2018.10.107", "30551389"]}, {"Citation": "Fox F.E., Niu Z., Tobia A., Rook A.H. Photoactivated Hypericin is an Anti-Proliferative Agent that Induces a High Rate of Apoptotic Death of Normal, Transformed, and Malignant T Lymphocytes: Implications for the Treatment of Cutaneous Lymphoproliferative and Inflammatory Disorders. J. Investig. Dermatol. 1998;111:327\u2013332. doi: 10.1046/j.1523-1747.1998.00278.x.", "ArticleIdList": ["10.1046/j.1523-1747.1998.00278.x", "9699738"]}, {"Citation": "Alecu M., Ursaciuc C., H\u00e3l\u00e3l\u00e3u F., Coman G., Merlevede W., Waelkens E., De Witte P. Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res. 1998;18:4651\u20134654.", "ArticleIdList": ["9891535"]}, {"Citation": "Kacerovsk\u00e1 D., Pizinger K., Majer F., \u0160m\u00edd F. Photodynamic therapy of nonmelanoma skin cancer with topical Hypericum perforatum extract\u2014A pilot study. Photochem. Photobiol. 2008;84:779\u2013785. doi: 10.1111/j.1751-1097.2007.00260.x.", "ArticleIdList": ["10.1111/j.1751-1097.2007.00260.x", "18179625"]}, {"Citation": "Head C.S., Luu Q., Sercarz J., Saxton R. Photodynamic therapy and tumor imaging of hypericin-treated squamous cell carcinoma. World J. Surg. Oncol. 2006;4:87. doi: 10.1186/1477-7819-4-87.", "ArticleIdList": ["10.1186/1477-7819-4-87", "PMC1762016", "17147827"]}, {"Citation": "Eastman K.L., McFarland L.V., Raugi G.J. Buyer beware: A black salve caution. J. Am. Acad. Dermatol. 2011;65:e154\u2013e155. doi: 10.1016/j.jaad.2011.07.031.", "ArticleIdList": ["10.1016/j.jaad.2011.07.031", "22000889"]}, {"Citation": "Saltzberg F., Barron G., Fenske N. Deforming Self-Treatment with Herbal \u201cBlack Salve\u201d. Dermatol. Surg. 2009;35:1152\u20131154. doi: 10.1111/j.1524-4725.2009.01206.x.", "ArticleIdList": ["10.1111/j.1524-4725.2009.01206.x", "19438678"]}, {"Citation": "Osswald S.S., Elston D.M., Farley M.F., Alberti J.G., Cordero S.C., Kalasinsky V.F. Self-treatment of a basal cell carcinoma with \u201cblack and yellow salve\u201d. J. Am. Acad. Dermatol. 2005;53:508\u2013510. doi: 10.1016/j.jaad.2005.04.007.", "ArticleIdList": ["10.1016/j.jaad.2005.04.007", "16112364"]}, {"Citation": "Affleck A.G., Varma S. A case of do-it-yourself Mohs\u2019 surgery using bloodroot obtained from the internet. Br. J. Dermatol. 2007;157:1078\u20131079. doi: 10.1111/j.1365-2133.2007.08180.x.", "ArticleIdList": ["10.1111/j.1365-2133.2007.08180.x", "17854372"]}, {"Citation": "McDaniel S., Goldman G.D. Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer. Arch. Dermatol. 2002;138:1593\u20131596. doi: 10.1001/archderm.138.12.1593.", "ArticleIdList": ["10.1001/archderm.138.12.1593", "12472348"]}, {"Citation": "Brown C.W., Goldstein G.D., Birkby C.S. Auto-Mohs.com. Dermatol. Surg. 2001;27:975\u2013978.", "ArticleIdList": ["11737136"]}, {"Citation": "Es-saady D., Simon A., Ollier M., Maurizis J.C., Chulia A.J., Delage C. Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest. Cancer Lett. 1996;106:193\u2013197. doi: 10.1016/0304-3835(96)04312-1.", "ArticleIdList": ["10.1016/0304-3835(96)04312-1", "8844972"]}, {"Citation": "Junco J.J., Cho J., Mancha A., Malik G., Wei S.J., Kim D.J., Liang H., DiGiovanni J., Slaga T.J. Role of AMPK and PPAR\u03b1 in the anti-skin cancer effects of ursolic acid. Mol. Carcinog. 2018;57:1698\u20131706. doi: 10.1002/mc.22890.", "ArticleIdList": ["10.1002/mc.22890", "PMC6519015", "30129681"]}, {"Citation": "Ruan J., Liu Y., Zhang L., Yan L., Fan F., Shen C., Wang A., Zheng S., Wang S., Lu Y. Luteolin reduces the invasive potential of malignant melanoma cells by targeting \u03b23 integrin and the epithelial-mesenchymal transition. Acta Pharmacol. Sin. 2012;33:1325\u20131331. doi: 10.1038/aps.2012.93.", "ArticleIdList": ["10.1038/aps.2012.93", "PMC4002713", "22983392"]}, {"Citation": "Iwashita K., Kobori M., Yamaki K., Tsushida T. Flavonoids inhibit cell growth and induce apoptosis in b16 melanoma 4A5 cells. Biosci. Biotechnol. Biochem. 2000;64:1813\u20131820. doi: 10.1271/bbb.64.1813.", "ArticleIdList": ["10.1271/bbb.64.1813", "11055382"]}, {"Citation": "Matsuda H., Nakashima S., Oda Y., Nakamura S., Yoshikawa M. Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells. Bioorg. Med. Chem. 2009;17 doi: 10.1016/j.bmc.2009.06.057.", "ArticleIdList": ["10.1016/j.bmc.2009.06.057", "19615910"]}, {"Citation": "Verschooten L., Smaers K., Van Kelst S., Proby C., Maes D., Declercq L., Agostinis P., Garmyn M. The flavonoid luteolin increases the resistance of normal, but not malignant keratinocytes, against UVB-induced apoptosis. J. Investig. Dermatol. 2010;130:2277\u20132285. doi: 10.1038/jid.2010.124.", "ArticleIdList": ["10.1038/jid.2010.124", "20463691"]}, {"Citation": "Afaq F., Adhami V.M., Ahmad N. Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol. Appl. Pharmacol. 2003;186:28\u201337. doi: 10.1016/S0041-008X(02)00014-5.", "ArticleIdList": ["10.1016/S0041-008X(02)00014-5", "12583990"]}, {"Citation": "Ahmad N., Adhami V.M., Afaq F., Feyes D.K., Mukhtar H. Resveratrol causes WAF-1/p21-mediated G1-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 2001;7:1466\u20131473.", "ArticleIdList": ["11350919"]}, {"Citation": "Hail N., Lotan R. Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. J. Natl. Cancer Inst. 2002;94:1281\u20131292. doi: 10.1093/jnci/94.17.1281.", "ArticleIdList": ["10.1093/jnci/94.17.1281", "12208893"]}, {"Citation": "US20100166895A1\u2014Capsicum Extract for Treatment of Skin Cancer\u2014Google Patents\u2019.  [(accessed on 15 November 2020)]; Available online:  https://patents.google.com/patent/US20100166895."}, {"Citation": "Rademan S., Anantharaju P.G., Madhunapantula S.V., Lall N. The anti-proliferative and antioxidant activity of four indigenous South African plants. Afr. J. Tradit. Complement. Altern. Med. 2019;16:13\u201323. doi: 10.21010/ajtcam.v16i1.2.", "ArticleIdList": ["10.21010/ajtcam.v16i1.2"]}, {"Citation": "Rezadoost M.H., Kumleh H.H., Ghasempour A. Cytotoxicity and apoptosis induction in breast cancer, skin cancer and glioblastoma cells by plant extracts. Mol. Biol. Rep. 2019;46:5131\u20135142. doi: 10.1007/s11033-019-04970-w.", "ArticleIdList": ["10.1007/s11033-019-04970-w", "31317456"]}, {"Citation": "Twilley D., Kishore N., Meyer D., Kumar V. Lall The Effect of Helichrysum odoratissimum (L.) Sweet on Cancer Cell Proliferation and Cytokine Production. Int. J. Pharmacogn. Phytochem. Res. 2017;9 doi: 10.25258/phyto.v9i2.8138.", "ArticleIdList": ["10.25258/phyto.v9i2.8138"]}, {"Citation": "Twilley D., Langhansov\u00e1 L., Palaniswamy D., Lall N. Evaluation of traditionally used medicinal plants for anticancer, antioxidant, anti-inflammatory and anti-viral (HPV-1) activity. S. Afr. J. Bot. 2017;112:494\u2013500. doi: 10.1016/j.sajb.2017.05.021.", "ArticleIdList": ["10.1016/j.sajb.2017.05.021"]}, {"Citation": "Vijaybabu K., Punnagai K. In-vitro anti-proliferative effects of ethanolic extract of vanilla planifolia leaf extract against A431 human epidermoid carcinoma cells. Biomed. Pharmacol. J. 2019;12:1141\u20131146."}, {"Citation": "Iliescu I.A., Peter S., Albert I., Skalicka-Wo\u017aniak K., Miron A., Luca S.V., Wolfram E. Verbascum nigrum: Cytotoxicity Evaluation in A431 Epidermoid Carcinoma Cells and Untargeted LC-HR-MS/MS Metabolite Profiling. Chem. Biodivers. 2020;17:e2000644. doi: 10.1002/cbdv.202000644.", "ArticleIdList": ["10.1002/cbdv.202000644", "33119147"]}, {"Citation": "Kessels J., Voeten L., Nelemans P., Cleutjens J., Hillen L.M., Mosterd K., Kelleners-Smeets N.W.J. Topical sinecatechins, 10%, ointment for superficial basal cell carcinoma: A randomized clinical trial. JAMA Dermatol. 2017;153:1061\u20131063. doi: 10.1001/jamadermatol.2017.2529.", "ArticleIdList": ["10.1001/jamadermatol.2017.2529", "PMC5817560", "28793140"]}, {"Citation": "Kuttan R., Sudheeran P.C., Josph C.D. Turmeric and curcumin as topical agents in cancer therapy. Tumori. 1987;73:29\u201331. doi: 10.1177/030089168707300105.", "ArticleIdList": ["10.1177/030089168707300105", "2435036"]}, {"Citation": "Sonavane K., Phillips J., Ekshyyan O., Moore-Medlin T., Roberts Gill J., Rong X., Lakshmaiah R.R., Abreo F., Boudreaux D., Clifford J.L., et al. Topical Curcumin-Based Cream Is Equivalent to Dietary Curcumin in a Skin Cancer Model. J. Skin Cancer. 2012;2012:1\u20139. doi: 10.1155/2012/147863.", "ArticleIdList": ["10.1155/2012/147863", "PMC3532873", "23316365"]}, {"Citation": "Lu Y.P., Lou Y.R., Xie J.G., Peng Q.Y., Liao J., Yang C.S., Huang M.T., Conney A.H. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. USA. 2002;99:12455\u201312460. doi: 10.1073/pnas.182429899.", "ArticleIdList": ["10.1073/pnas.182429899", "PMC129466", "12205293"]}, {"Citation": "Pflugfelder A., Andonov E., Weide B., Dirschka T., Schempp C., Stockfleth E., Stratigos A., Kr\u00fcger-Krasagakis S., Bauer J., Garbe C., et al. Lack of activity of betulin-based Oleogel-S10 in the treatment of actinic keratoses: A randomized, multicentre, placebo-controlled double-blind phase II trial. Br. J. Dermatol. 2015;172:926\u2013932.", "ArticleIdList": ["25124939"]}, {"Citation": "Lim A. Black salve treatment of skin cancer: A review. J. Dermatolog. Treat. 2018;29:388\u2013392.", "ArticleIdList": ["29098921"]}, {"Citation": "Croaker A., King G.J., Pyne J.H., Anoopkumar-Dukie S., Simanek V., Liu L. Carcinogenic potential of sanguinarine, a phytochemical used in \u2018therapeutic\u2019 black salve and mouthwash. Mutat. Res. Rev. Mutat. Res. 2017;774:46\u201356. doi: 10.1016/j.mrrev.2017.09.001.", "ArticleIdList": ["10.1016/j.mrrev.2017.09.001", "29173498"]}, {"Citation": "Huyke C., Reuter J., Rodig M., Kersten A., Laszczyk M., Scheffler A., Nashan D., Schempp C. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study. J. Dtsch. Dermatol. Ges. 2009;7:128\u2013133. doi: 10.1111/j.1610-0387.2008.06865.x.", "ArticleIdList": ["10.1111/j.1610-0387.2008.06865.x", "18808378"]}, {"Citation": "Camptothecin|C20H16N2O4\u2014PubChem\u2019.  [(accessed on 17 November 2020)]; Available online:  https://pubchem.ncbi.nlm.nih.gov/compound/Camptothecine."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "12"}, {"Year": "2021", "Month": "3", "Day": "12"}, {"Year": "2021", "Month": "3", "Day": "20"}, {"Year": "2021", "Month": "4", "Day": "30", "Hour": "1", "Minute": "1"}, {"Year": "2021", "Month": "5", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["33915735", "PMC8037492", "10.3390/molecules26071979", "molecules26071979"]}}], "PubmedBookArticle": []}